<DOC>
	<DOCNO>NCT01350934</DOCNO>
	<brief_summary>This study evaluate whether weekly administration combination tablet alendronate/vitamin D3 ( FOSAMAX PLUS ) increase lumbar spine bone mineral density ( BMD ) daily use calcitriol .</brief_summary>
	<brief_title>A Study Evaluate Alendronate Sodium /Vitamin D3 Combination Tablets ( FOSAMAX PLUS ) Versus Calcitriol Treatment Osteoporosis Postmenopausal Women China ( MK-0217A-264 )</brief_title>
	<detailed_description>This 6-month , randomize , open-label , active-comparator control , parallel-group study 6-month extension evaluate safety efficacy alendronate sodium 70 mg plus vitamin D3 5600 IU combination tablet versus calcitriol treatment osteoporosis postmenopausal woman China . Participants randomly assign receive alendronate 70 mg plus vitamin D3 5600 IU combination tablet weekly orally calcitriol 0.25 μg daily orally .</detailed_description>
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Osteoporosis , Postmenopausal</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Calcitriol</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<mesh_term>Alendronate</mesh_term>
	<criteria>Meets one follow BMD criterion : Has BMD Tscore ≤2.5 least one anatomic sit include lumbar spine , total hip , femoral neck , OR Has prior nonpathological fragility fracture ( spine , wrist , humerus clavicle ) BMD Tscore ≤1.5 least one anatomic sit include lumbar spine , total hip , femoral neck site Must baseline 25hydroxyvitamin D ≥8 ng/mL ( 20 nmol/L ) Is ambulatory Has postmenopausal least one year Has contraindication alendronate , include abnormality esophagus delay esophageal empty ( stricture achalasia ) , inability stand/sit upright least 30 minute , hypersensitivity alendronate vitamin D , hypocalcemia Has contraindication calcitriol , and/or vitamin D , include hypercalcemia , hypercalciuria , active kidney stone disease Had prior hip fracture Has receive treatment follow : anabolic steroid agent within past 12 month , systemic glucocorticoid 2 week past 6 month , oral bisphosphonates 3 month within past 2 year , lifetime use intravenous administration zoledronate , immunosuppressant methotrexate , fluoride treatment dose great 1 mg/day 2 week within past 3 month , strontium containing product 2 week within past 6 month , Parathyroid hormone 2 week within past 3 month , current use chemotherapy , heparin , growth hormone 2 week within past 6 month , active hormonal vitamin D analog ( e.g. , alphacalcidol , calcitriol ) past 30 day , 5 day treatment active hormonal vitamin D analogs 30 60 day prior study entry. , use vitamin A ( exclude beta carotene ) &gt; 10,000 IU daily , unless willing discontinue dose study , current use , lithium , anticonvulsant , current use calcium supplement amount excess 1500 mg daily , unless willing discontinue dose study , estrogen without progestin within prior 6 month , Raloxifene selective estrogen receptor modulator ( [ SERM ] include tamoxifen ) , tibolone , aromatase inhibitor within prior 6 month and/or subcutaneous calcitonin intranasal calcitonin within prior 6 month Has history malignancy within previous 5 year Has one follow concomitant condition : uncontrolled upper gastrointestinal disorder , myocardial infarction , unstable angina , stroke revascularization condition within 3 month , malabsorption syndrome , uncontrolled primary secondary hyperparathyroidism , uncontrolled thyroid disease , renal insufficiency , uncontrolled genitourinary , cardiovascular , hepatic , renal , endocrine , hematologic , neurological , psychiatric , pulmonary disease ; unexplained laboratory test abnormality condition , uncontrolled hypertension , new onset diabetes ( within 3 month ) , poorly control hyperglycemia abnormal fast glucose , hypoglycemia cause , history , evidence metabolic bone disease osteoporosis , abnormal serum calcium phosphate , and/or active renal stone disease calcium supplement contraindicate</criteria>
	<gender>Female</gender>
	<minimum_age>56 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>